Table 2 Summary of the most recent case reports including case 1 (patient A)^a and 2 (patient B)^b. n = 14

M/24^a

TnT 504 ng/L

ST-elevation

Normal, LVEF 60–65 %

No

Azithromycin

Full recovery

M/23^b

TnT 128 ng/L

Normal

Normal incl LVEF

No

Azithromycin

Full recovery

M/60 [6]

N/A

N/A

Pericard effusion

No

Ceftriaxone/Meropenem

Diarroea

M/43 [7]

TnT 1.75 ng/ml

ST-elevation

Abn wall motion LVEF 68 %

Subepi/myocardial enhancement

Azithromycin

N/A

M/33 [8]

TnI 18.6mcg/L

ST-elevation

LVEF 56 %

Increased signal subepi, dilated LV/RV

Roxithromycin

N/A

M/17 [9]

TnI 16.8 ng/mL

ST-elevation

Normal

Subepicardial enhancement

Azithromycin

Full recovery

M/21 [5]

TnI 15.6 ng/ml

Normal

Decreased LVEF

Subepi/myocardial enhancement

Azithromycin

Almost full rec

M/24 [5]

TnI 8.9 mcg/L

ST-elevation

LVEF 40 %

Subepicardial enhancement

No

Full recovery

M/42 [5]

TnI 11.6mcg/L

ST-elevation

LVEF 40 %

Subepicardial enhancement

Ciprofloxacin

Full recovery

M/21 [10]

TnI 39.8mcg/L

ST-elevation

Normal inkc LVEF

No

Ciprofloxacin

Full recovery

M/21 [11]

TnI 2.5mcg/L

ST-elevation

Normal incl LVEF

No

Yes(unknown kind)

Full recovery

M/24 [12]

CK normal

Arrythmia

Decreased LVEF/peric effusion

No

Roxithromycin

N/A

M/19 [13]

TnT 0.52 ng/mL

Strain

N/A

Yes

N/A

N/A

M/16 [14]

TnT 1.7 ng/mL

ST-elevation

LVEF 45 %

No

Clarythromycin

Full recovery

M/17 [14]

TnT 0.9 ng/mL

ST-elevation

Normal incl LVEF

Myocardial enhancement

Clarythromycin

Full recovery